BioCryst Pharmaceuticals, Inc.
BCRX
$9.81
$0.657.10%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 274.75M | 212.87M | 260.04M | 295.09M | 320.85M |
| Total Receivables | 106.82M | 91.33M | 91.18M | 93.39M | 79.07M |
| Inventory | 5.40M | 5.23M | 5.04M | 6.87M | 8.09M |
| Prepaid Expenses | 17.18M | 16.50M | 12.54M | 14.33M | 13.75M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 201.00K | 29.75M | 29.66M | 291.00K | 210.00K |
| Total Current Assets | 404.35M | 355.68M | 398.46M | 409.98M | 421.97M |
|
|
|||||
| Total Current Assets | 404.35M | 355.68M | 398.46M | 409.98M | 421.97M |
| Net Property, Plant & Equipment | 18.99M | 19.24M | 20.00M | 19.58M | 19.79M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 29.66M | 31.84M | 28.62M | 29.95M | 28.34M |
| Total Assets | 514.16M | 446.42M | 457.19M | 480.05M | 490.42M |
|
|
|||||
| Total Accounts Payable | 15.83M | 5.57M | 8.59M | 10.05M | 11.64M |
| Total Accrued Expenses | 126.41M | 118.78M | 107.11M | 92.64M | 113.29M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 40.08M | 39.47M | 37.75M | 37.17M | 35.45M |
| Total Finance Division Other Current Liabilities | 13.74M | 26.42M | 23.71M | -- | -- |
| Total Other Current Liabilities | 13.74M | 26.42M | 23.71M | -- | -- |
| Total Current Liabilities | 196.07M | 190.24M | 177.16M | 139.86M | 160.38M |
|
|
|||||
| Total Current Liabilities | 196.07M | 190.24M | 177.16M | 139.86M | 160.38M |
| Long-Term Debt | 427.23M | 633.47M | 690.64M | 782.03M | 795.92M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 10.01M | 10.17M | 10.53M | 10.09M | 10.05M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 436.00K | 454.00K | -- | -- |
| Total Liabilities | 633.31M | 834.31M | 878.78M | 931.97M | 966.35M |
|
|
|||||
| Common Stock & APIC | 1.39B | 1.36B | 1.34B | 1.32B | 1.29B |
| Retained Earnings | -1.51B | -1.75B | -1.76B | -1.77B | -1.77B |
| Treasury Stock & Other | 38.00K | 1.14M | 1.65M | 1.13M | 921.00K |
| Total Common Equity | -119.15M | -387.89M | -421.59M | -451.93M | -475.93M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -119.15M | -387.89M | -421.59M | -451.93M | -475.93M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -119.15M | -387.89M | -421.59M | -451.93M | -475.93M |
|
|
|||||